Media coverage: Phase III clinical trial in stroke disability (PISCES-III)

Proactive Investors ‘ReNeuron Group’s phase IIb stroke trial kicks off with first patient treated’

Proactive Investors: ReNeuron gears up for Phase III stroke disability study

Proactive Investors: ReNeuron ‘greatly encouraged’ by US regulator feedback on CTX cell therapy trial